磷酸化蛋白激酶AKT1抗体

¥1280
WCYI
中国
2021-06-11 17:00

上海晚成医疗器械有限公司

我要认领
上海晚成医疗器械有限公司
郎经理
17316390557 400-006-1850
2465160202@qq.com
产品属性
免疫原KLH conjugated synthetic peptide derived from human TATA binding protein TBP
亚型IgG
形态Lyophilized or Liquid
克隆性多克隆
浓度1mg/1ml
抗体英文名phospho-AKT1 (Tyr474)
规格0.1ml
产品说明
AKT, also known as protein kinase B (PKB), is a 57 kDa serine/threonine protein kinase. There are three mammalian isoforms of Akt: AKT1 (PKB alpha), AKT2 (PKB beta) and AKT3 (PKB gamma) with AKT2 and AKT3 being approximately 82% identical with the AKT1 isoform. Each isoform has a pleckstrin homology (PH)domain, a kinase domain and a carboxy terminal regulatory domain. AKT was originally cloned from the retrovirus AKT8, and is a key regulator of many signal transduction pathways. Its tight control over cell proliferation and cell viability are manifold; overexpression or inappropriate activation of AKT has been seen in many types of cancer. AKT mediates many of the downstream events of phosphatidylinositol 3 kinase (a lipid kinase activated by growth factors, cytokines and insulin). PI3 kinase recruits AKT to the membrane, where it is activated by PDK1 phosphorylation. Once phosphorylated, AKT dissociates from the membrane and phosphorylates targets in the cytoplasm and the cell nucleus.